Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Overview of attention for article published in Lung Cancer (01695002), May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 1 public wall post.

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of https://t.co/egLU1KSGhm #hvh…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.